0001161697-20-000604.txt : 20201228
0001161697-20-000604.hdr.sgml : 20201228
20201228164729
ACCESSION NUMBER: 0001161697-20-000604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGENITO GARY
CENTRAL INDEX KEY: 0001279473
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 201418858
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1500
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 12-22-2020
X0306
4
2020-12-22
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001279473
INGENITO GARY
355 ALHAMBRA CIRCLE, SUITE 1250
CORAL GABLES
FL
33134
0
1
0
0
Chief Medical Officer
Common stock, par value $0.001 per share
2020-12-22
4
M
0
14666
A
14666
D
Common stock, par value $0.001 per share
2020-12-22
4
S
0
3668
3.447
D
10998
D
Restricted Stock Units
2020-12-22
4
M
0
14666
0
D
Common Stock
14666
871334
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies and practices. Dr. Ingenito remains an officer of the Company.
Dr. Ingenito sold the shares on the open market to pay for taxes due on the vesting of the restricted stock units.
Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 22, 2020.
/s/ Gary Ingenito
2020-12-23